This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease
Nature Communications Open Access 04 May 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Cassidy, S., Syed, B. Nonalcoholic steatohepatitis (NASH) drugs market. Nat Rev Drug Discov 15, 745–746 (2016). https://doi.org/10.1038/nrd.2016.188
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2016.188
This article is cited by
-
Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease
Nature Communications (2023)
-
WZ66, a novel acetyl-CoA carboxylase inhibitor, alleviates nonalcoholic steatohepatitis (NASH) in mice
Acta Pharmacologica Sinica (2020)
-
Evaluating the Relationship Between Lean Liver Volume and Fat-Free Mass
Clinical Pharmacokinetics (2020)
-
Novel substituted pyrazolone derivatives as AMP-activated protein kinase activators to inhibit lipid synthesis and reduce lipid accumulation in ob/ob mice
Acta Pharmacologica Sinica (2018)